Xiaotong Lu has a diverse work experience. They began their career as an Undergraduate Research Assistant at Jilin University, where they worked on establishing an infectious model of Enterovirus71 (EV71) and evaluating the protective effects of Retro-2.1 against it. They then joined the Chinese Academy of Sciences as a Research Assistant, contributing to a project focused on interpreting the mechanism of antitumor drug candidates that target the PI3K/Akt signaling pathway.
After that, Xiaotong Lu pursued their graduate studies at Rice University. During their time there, they served as a Graduate Student, working on two projects. The first project involved solving the atomic structure of the Influenza Virus Matrix Protein and studying its biochemical function. The second project focused on the histone H3 transferase activity of KAT2A and identifying specific residues involved in the binding site. They also took on the role of Graduate Teaching Assistant for a Biochemistry class.
Additionally, Xiaotong Lu held a leadership position as Vice President at Rice University RCSSA, where they were responsible for external affairs and collaborated with various sponsors and student organizations.
Currently, Xiaotong Lu works as a Scientist 1 at Lyterian Therapeutics, although specific details about their role have not been provided.
Xiaotong Lu completed a Bachelor of Science (BS) in Pharmaceutical Engineering at Jilin University from 2012 to 2016. After that, from 2016 to 2017, Xiaotong Lu worked as a Research Assistant at the Chinese Academy of Sciences, focusing on Tumor Targeted Therapy and Immunotherapy. They then pursued a Doctor of Philosophy (PhD) in Structural Biology at Rice University from 2017 to 2023. Following the completion of their PhD, Xiaotong Lu continued their education at Rice University, undertaking a Master's degree program in Computer Science, which began in 2022 and is expected to end in 2023.
Sign up to view 0 direct reports
Get started